Press Release 2021 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Sami-Sabinsa to Introduce New Products and the Most Recent Book on Ashwagandha by Dr. Muhammed Majeed at SupplySide West

Sami-Sabinsa to Showcase New Products, Host Event at Vitafoods Europe

Sami-Sabinsa’s Postbiotic LactoSporin® Wins 1st Place in NIE Awards

Sami-Sabinsa Names Dr. Umar Jan as President of European Operations

Sami-Sabinsa Expands UK and EU Footprint with New Staff

Sami-Sabinsa Reaches Intellectual Property Milestone with over 300 Patents Granted

Certificates

Global Offices

Get in Touch

Disclaimer